Aug 4, 2026 01:08PM
Aug 4, 2026 07:28AM
Aug 4, 2026 07:00AM
Jul 28, 2026 07:00AM
May 13, 2026 06:05AM
May 12, 2026 07:07AM
May 12, 2026 07:05AM Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 5, 2026 07:00AM
Feb 24, 2026 07:08AM
Feb 24, 2026 07:00AM
Feb 17, 2026 07:00AM
Jan 8, 2026 04:30PM
Jan 8, 2026 04:30PM
Nov 5, 2025 07:18AM Arvinas, Inc. (ARVN) Tops Q3 EPS by 23c
Nov 5, 2025 07:00AM
Oct 29, 2025 07:00AM
Aug 7, 2025 06:53AM
Aug 6, 2025 07:50AM
Aug 6, 2025 07:00AM
Jul 30, 2025 04:05PM
May 31, 2025 08:00AM Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
May 31, 2025 08:00AM
May 2, 2025 05:35AM
May 1, 2025 07:07AM
May 1, 2025 07:00AM
Apr 28, 2025 07:00AM
Mar 11, 2025 06:46AM
Mar 11, 2025 06:45AM Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
Feb 11, 2025 07:03AM
Feb 11, 2025 07:00AM
Feb 3, 2025 07:00AM
Dec 10, 2024 09:09AM
Dec 10, 2024 09:05AM
Oct 30, 2024 07:11AM
Oct 30, 2024 07:00AM Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Oct 21, 2024 07:00AM
Oct 1, 2024 06:47AM
Jul 30, 2024 09:30AM
Jul 30, 2024 07:00AM
May 16, 2024 06:01AM
May 16, 2024 06:00AM
May 7, 2024 07:33AM Arvinas, Inc. (ARVN) Tops Q1 EPS by 43c
May 7, 2024 07:00AM
Feb 27, 2024 07:00AM
Feb 6, 2024 06:46AM
Feb 6, 2024 06:45AM
Dec 5, 2023 01:36PM
Dec 5, 2023 01:33PM
Nov 28, 2023 05:05PM Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium
Nov 7, 2023 07:21AM

1,215,883 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All